주요 콘텐츠로 건너뛰기
번역 진행 중 — 귀하의 언어 버전을 준비하는 동안 이 콘텐츠가 영어로 표시됩니다.
토론으로 돌아가기

Evolving Health and Wellbeing of Thalidomide Survivors as They Age

Healthcare
글로벌
September 17, 2026에 시작됨

This scoping review updates the 2017 review by exploring evidence published 2017-2025 on the physical, mental, and social wellbeing of ageing thalidomide survivors, identifying emerging health issues, care needs, and evidence gaps

출처 기사

진술 추가 분석 0/5
Need to find a specific claim? Search all statements.
🗳️ Join the conversation
10 투표할 진술 • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (10+ recommended) 10/10
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM 게시자: admin • Sep 17, 2026
Evidence on the long-term health trajectories of thalidomide survivors must be systematically gathered and shared with clinicians treating this aging population.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results
CLAIM 게시자: admin • Sep 17, 2026
Survivors' lived experience and self-reported health concerns should shape research priorities as much as clinical datasets.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results
CLAIM 게시자: admin • Sep 17, 2026
Surviving thalidomide exposure does not automatically increase risk of age-related disease beyond the general population.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results
CLAIM 게시자: admin • Sep 17, 2026
The government must implement policies that ensure comprehensive support for the aging population of thalidomide survivors.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results
CLAIM 게시자: admin • Sep 17, 2026
The current healthcare system fails to adequately support the evolving needs of thalidomide survivors as they age.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results
CLAIM 게시자: admin • Sep 17, 2026
Thalidomide survivors do not need special considerations in healthcare beyond what is offered to other aging populations.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results
CLAIM 게시자: admin • Sep 17, 2026
Cross-national data on thalidomide survivor aging outcomes is fragmented and should be pooled into a coordinated international registry.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results
CLAIM 게시자: admin • Sep 17, 2026
Thalidomide survivors should have prioritized access to mental health services as they age.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results
CLAIM 게시자: admin • Sep 17, 2026
The unique needs of thalidomide survivors should be integrated into mainstream aging and disability policies.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results
CLAIM 게시자: admin • Sep 17, 2026
Whether survivors receive compensation or not, healthcare systems must prepare now for emerging age-related conditions unique to this cohort.

번역 대기 중

Vote options for this statement: agree, disagree, or unsure
💬 토론 보기
Be first to respond
Vote to see results

💡 How This Works

  • • Add Statements: Post claims or questions (10-500 characters)
  • • Vote: Agree, Disagree, or Unsure on each statement
  • • Respond: Add detailed pro/con responses with evidence
  • • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us